Navigation Links
CellThera and WPI advance in regeneration study
Date:3/23/2009

WORCESTER, Mass. CellThera, a biotechnology company located in Worcester Polytechnic Institute's Life Sciences and Bioengineering Center at Gateway Park, has received a contract from the U.S. Defense Advanced Research Projects Agency (DARPA) to extend its research program in tissue regeneration. Under the terms of the contract, CellThera, which is part of WPI's Bioengineering Institute (BEI), and the university will continue their joint efforts aimed at restoring tissues damaged or lost due to traumatic injury.

"We are very pleased to be moving into the next phase of this work," said Raymond Page, PhD, research assistant professor in BEI and WPI's Department of Biology and Biotechnology, who serves as the principal investigator for WPI's portion of the program. "The collaboration between WPI and CellThera continues to grow and show progress. We look forward to tackling the challenges ahead."

DARPA, which serves as the research and development wing of the U.S. Defense Department, awarded CellThera a one-year $570,000 contract, with an option to extend for a second year, to fund studies aimed at regenerating mammalian muscle tissue. CellThera, in turn, subcontracted with WPI for certain elements of the research. This joint research model was established in 2006, when DARPA funded the first phase of the tissue regeneration program. In that initial phase of the research, the CellThera/WPI team, working in conjunction with colleagues at Tulane University, succeeded in reprogramming mouse and human skin cells to act more like stem cells, able to form the early structures needed to begin the process of re-growing lost tissues.

In the new phase of the program, the CellThera/WPI team will try to reprogram and engineer cells to replace damaged skeletal muscle and to restore the normal function of that muscle. Joining the effort for the new phase of this work will be George Pins, PhD, associate professor of biomedical engineering at WPI, who has pioneered novel cell-delivery strategies that will be useful for the project. The new phase also involves collaboration with the clinical research team led by Raymond Dunn, MD, professor of surgery and cell biology at the University of Massachusetts Medical School and chief of plastic and reconstructive surgery at UMass Memorial Medical Center.

"This new award not only validates the important work CellThera and WPI are doing in the area of regenerative medicine, but by bringing together basic science, engineering and the clinical expertise of UMass, along with the commercial strength in the Worcester region, this work will help push the science closer to the clinic and closer to helping people recover from devastating injuries," said Eric W. Overstrm, PhD, professor and head of WPI's Department of Biology and Biotechnology.

The long-range goal of the DARPA program is to find ways to harness the body's natural regenerative abilities to heal wounds that involve bone, muscle, nerves, and soft tissue. The impetus for the program is to develop new therapies for soldiers who return home from war with major injuries. If successful, however, the science will have a broad range of civilian applications, as well. "Translating basic science advances into products and technologies that can improve people's lives is BEI's core mission," said BEI Director W. Grant McGimpsey, PhD. "So it's exciting to see the talented teams at CellThera, WPI and UMass Medical School working together seamlessly to advance this program."


'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert

Related biology news :

1. U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support
2. Salient Stills Notches Significant Advances in Profitability, Diversity of Sales and Customers, and Video Forensics Technology in 2008
3. Iowa Power Fund advances researcher’s long quest for efficient solar power
4. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
5. Advancement in tissue engineering promotes oral wound healing
6. Evolution and climate change research advances at Rutgers-Camden
7. Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009
8. 13 UCR faculty members recognized by American Association for the Advancement of Science
9. American Association for the Advancement of Science honors four Iowa Staters
10. Researchers advance knowledge of little nano-machines in our body
11. TECNALIA investigates advanced biomaterials to make more reliable and hardwearing medical implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
Breaking Biology Technology: